Search clinical trials for: INXN-4001
Total 1939 results
-
Alaunos TherapeuticsCompletedMelanomaUnited States
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompletedGlioblastoma Multiforme | Anaplastic OligoastrocytomaUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Triple-Gene, LLCIntrexon Corporation; Precigen, IncCompletedCardiovascular Diseases | Heart Failure | Heart-Assist DeviceUnited States
-
9 Meters Biopharma, Inc.Completed
-
9 Meters Biopharma, Inc.Completed
-
9 Meters Biopharma, Inc.Teva Pharmaceuticals USACompletedCeliac DiseaseUnited States, Canada
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada, Spain
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada
-
Introgen TherapeuticsUnknownCarcinoma, Squamous CellUnited States
-
University of CincinnatiCompletedEnd Stage Liver DiseaseUnited States
-
Introgen TherapeuticsM.D. Anderson Cancer CenterUnknownNeoplasm Metastasis | Malignant MelanomaUnited States
-
NeurAxon Inc.CompletedStudy of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without AuraMigraine Without AuraUnited States
-
NeurAxon Inc.CompletedPost Herpetic NeuralgiaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Department of Health and Human ServicesTerminated
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Bristol-Myers SquibbCompleted
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Introgen TherapeuticsCompletedLocally Advanced Breast Cancer (LABC)United States
-
Dong-A ST Co., Ltd.CompletedAndrogenic AlopeciaKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Bristol-Myers SquibbCompletedHealthy | Hepatitis CUnited States, Puerto Rico
-
9 Meters Biopharma, Inc.TerminatedCeliac DiseaseUnited States
-
CAGE Bio Inc.John Peter Smith HospitalRecruitingFungal Infection | Onychomycosis | Tinea UnguiumUnited States
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Stage 0 Lip and Oral Cavity Cancer | Stage 0 Oropharyngeal CancerUnited States
-
Thallion PharmaceuticalsCompletedGlioma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | TumorsCanada
-
Chiesi Farmaceutici S.p.A.SGS S.A.Completed
-
Botanix PharmaceuticalsCompletedHyperhidrosisUnited States
-
Novo Nordisk A/SRecruitingHealthy Volunteers | Cardiometabolic DiseasesNetherlands
-
Novo Nordisk A/SActive, not recruitingTransthyretin Amyloid Cardiomyopathy (ATTR CM)United States, Netherlands, Spain, Portugal, Canada, Czechia, France, Germany, Italy, Japan
-
Thallion PharmaceuticalsTerminatedGlioblastoma MultiformeUnited States, Canada
-
RVAC Medicines (US), Inc.TerminatedCOVID-19 | Infectious DiseaseAustralia
-
Bristol-Myers SquibbCompleted
-
Botanix PharmaceuticalsCompletedHyperhidrosisUnited States
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseCanada, United States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AnGes USA, Inc.TerminatedCritical Limb IschemiaUnited States, France, Belgium, Canada, Poland, Finland, Denmark, Netherlands, Hungary, Italy, Sweden
-
Forma Therapeutics, Inc.ProSciento, Inc.TerminatedNonalcoholic Steatohepatitis (NASH) | Overweight or ObesityUnited States
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Stage IV Non-small Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedHCV (Genotype 1)United States, Puerto Rico
-
University of ChicagoAsphelia PharmaceuticalsCompletedAllergic RhinitisUnited States
-
IVIEW Therapeutics Inc.Not yet recruiting
-
Bioventus LLCTerminatedLumbar Degenerative Disc Disease
-
Bioventus LLCMcMaster University; Clinical Advances Through Research and Information TranslationTerminatedTibial FracturesUnited States, Canada
-
Mitsubishi Tanabe Pharma CorporationTerminatedChronic Kidney Disease | Hyperphosphatemia | DialysisFrance, Poland, Spain, Serbia, South Africa, Czech Republic, Germany, Macedonia, The Former Yugoslav Republic of, Italy, United Kingdom
-
University of CalgaryBioventus LLC; Workers' Compensation Board, Alberta; Calgary Orthopaedic Research...Active, not recruitingFractures, Ununited | Nonunion of Fracture of Scaphoid BoneCanada
-
Bristol-Myers SquibbCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Kidney Disease | Hyperphosphatemia | DialysisUnited States, Puerto Rico